A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Public ClinicalTrials.gov record NCT02293395. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to estimate the risk of bleeding with rivaroxaban, compared with acetylsalicylic acid (ASA), in addition to a single antiplatelet/ platelet adenosine diphosphate P2Y12 receptor antagonist (P2Y12 inhibitor agent: clopidogrel or ticagrelor), in participants with a recent acute coronary syndrome (ACS: including ST segment elevation myocardial infarction \[STEMI\] and non-ST-segment elevation acute coronary syndrome \[NSTE-ACS\]).
Study identification
- NCT ID
- NCT02293395
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 3,037 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 20, 2015 (Actual)
- Primary completion
- Oct 14, 2016 (Actual)
- Completion
- Oct 14, 2016 (Actual)
- Last update posted
- Dec 26, 2017
2015 – 2016
United States locations
- U.S. sites
- 49
- U.S. states
- 22
- U.S. cities
- 49
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Alexander City | Alabama | — | — |
| Not listed | Banning | California | — | — |
| Not listed | Sylmar | California | — | — |
| Not listed | Aurora | Colorado | — | — |
| Not listed | Littleton | Colorado | — | — |
| Not listed | Jupiter | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Pensacola | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Athens | Georgia | — | — |
| Not listed | Cumming | Georgia | — | — |
| Not listed | Macon | Georgia | — | — |
| Not listed | Tucker | Georgia | — | — |
| Not listed | Boise | Idaho | — | — |
| Not listed | Coeur d'Alene | Idaho | — | — |
| Not listed | Jerseyville | Illinois | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Munster | Indiana | — | — |
| Not listed | Bay City | Michigan | — | — |
| Not listed | Kalamazoo | Michigan | — | — |
| Not listed | Lansing | Michigan | — | — |
| Not listed | Mount Clemens | Michigan | — | — |
| Not listed | Ypsilanti | Michigan | — | — |
| Not listed | Minneapolis | Minnesota | — | — |
| Not listed | Columbia | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Kalispell | Montana | — | — |
| Not listed | Stony Brook | New York | — | — |
| Not listed | Rocky Mount | North Carolina | — | — |
| Not listed | Sanford | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Zanesville | Ohio | — | — |
| Not listed | Bartlesville | Oklahoma | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Abington | Pennsylvania | — | — |
| Not listed | Langhorne | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Sayre | Pennsylvania | — | — |
| Not listed | York | Pennsylvania | — | — |
| Not listed | Rapid City | South Dakota | — | — |
| Not listed | Oak Ridge | Tennessee | — | — |
| Not listed | Amarillo | Texas | — | — |
| Not listed | Fort Sam Houston | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Odessa | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Danville | Virginia | — | — |
| Not listed | Puyallup | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 210 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02293395, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 26, 2017 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02293395 live on ClinicalTrials.gov.